| Literature DB >> 32662696 |
Morgan Thomas Rose1,2,3, Monica Slavin2,4,5, Jason Trubiano1,2,3,6.
Abstract
INTRODUCTION: Penicillin antibiotic allergy labels (AALs) are common and lead to significant negative health and health system outcomes. Direct oral challenge offers a rapid and cost-effective way of removing inaccurate AALs and improving outcomes. AREAS COVERED: A narrative review (Medline, May 2020) of direct oral challenge in low-risk penicillin allergy in adults is described, and the evidence for the safety and efficacy of this approach in inpatients, outpatients, and special patient groups is presented. EXPERT OPINION: Whilst the current literature demonstrates the safety and efficacy of direct oral challenge in de-labeling low-risk penicillin allergy in adults, novel approaches are needed to improve access to antibiotic allergy assessment and address the growing global need.Entities:
Keywords: Allergy; antibiotic; beta-lactam; de-labeling; oral challenge; penicillin
Mesh:
Substances:
Year: 2020 PMID: 32662696 DOI: 10.1080/14787210.2020.1792775
Source DB: PubMed Journal: Expert Rev Anti Infect Ther ISSN: 1478-7210 Impact factor: 5.091